{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: METHODS : The Assessment of Lisinopril and Survival study was a multicenter , randomized , double - blind trial in which patients with or without previous ACE inhibitor treatment were stabilized receiving medium - dose lisinopril ( 12 . 5 or 15 . 0 mg once daily [ OD ] ) for 2 to 4 weeks and then randomized to high - ( 35 . 0 or 32 . 5 mg OD ) or low - dose ( 5 . 0 or 2 . 5 mg OD ) groups .\n\nLet's think step by step."},
    {"role": "assistant", "content": "Sure! Here are the \"Disease\" entities identified in the paragraph:\n\n| Disease |\n| --- |\n| ACE inhibitor treatment |\n| previous ACE inhibitor treatment |"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "Of course! Here are the valid \"Disease\" entities identified in the paragraph:\n\n| Disease |\n| --- |\n| ACE inhibitor treatment |\n| ACE inhibitor treatment (previous) |"}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: METHODS : The Assessment of Lisinopril and Survival study was a multicenter , randomized , double - blind trial in which patients with or without previous ACE inhibitor treatment were stabilized receiving medium - dose lisinopril ( 12 . 5 or 15 . 0 mg once daily [ OD ] ) for 2 to 4 weeks and then randomized to high - ( 35 . 0 or 32 . 5 mg OD ) or low - dose ( 5 . 0 or 2 . 5 mg OD ) groups .\n\nLet's think step by step."},
    {"role": "assistant", "content": "Sure! Here are the \"Chemical\" entities mentioned in the paragraph:\n\n| Chemical |\n| --- |\n| Lisinopril |\n| ACE inhibitor |"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "Of course! Here are the valid \"Chemical\" entities mentioned in the paragraph:\n\n| Chemical |\n| --- |\n| Lisinopril |\n\nThe other entities in the paragraph (e.g. \"ACE inhibitor\") are not explicitly referring to a chemical entity, so they have been excluded from the table."}
  ]
}